SightfileU.S. market data from official filings

MACROGENICS INC (MGNX)

Name: MACROGENICS INC (MGNX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001125345 · EDGAR filings · Updated 2026-07-23

MACROGENICS INC (MGNX) has reported institutional ownership of 67.9%, with 109 institutional managers holding positions valued at $124.8M per the latest 13F reporting period.

Institutional ownership

67.9%

Institutional managers

109

Reported 13F value

$124.8M

Insider activity

51 trans.

$150.5K net buying

Filings this week (1)

2026-07-23 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-20 — SCHEDULE 13G/A filed
2026-07-13 — Notice of proposed sale filed (Form 144)
2026-07-08 — Current report (8-K) filed
2026-07-07 — Current report (8-K) filed
2026-06-05 — SCHEDULE 13G filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MACROGENICS INC has 109 institutional holders and institutional ownership of 67.9%.

Insider activity

Insiders reported 51 transactions (2 buys, 0 sells) across 16 reporting insiders, with a net reported value of $150.5K.

Related companies

INNOVAGE HLDG CORP (INNV) · EDITAS MEDICINE INC (EDIT) · HERON THERAPEUTICS INC (HRTX) · CRONOS GROUP INC (CRON) · Anavex Life Sciences (AVXL) · NKARTA INC (NKTX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.